Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Fulcrum Therapeutics, Inc. | President & Chief Executive Officer, Director | Stock Option (right to buy) | 340K | Jan 19, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
FULC | Fulcrum Therapeutics, Inc. | Jan 19, 2022 | 1 | $0 | 4 | Jan 21, 2022 | President & Chief Executive Officer, Director |
FULC | Fulcrum Therapeutics, Inc. | Aug 10, 2021 | 6 | -$755K | 4 | Aug 12, 2021 | President & Chief Executive Officer, Director |